Nanodiamond and nanoplatinum liquid, DPV576, activates human monocyte-derived dendritic cells in vitro

Anticancer Research

Volumn 30, Issue 10, 2010, Pages 4075-4079

  Ghoneum, Mamdooh ^a   Ghoneum, Alia ^a,b   Gimzewski, James ^b  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bionanotechnology; CD4+ cells; Dendritic cells; In vitro; Nanodiamond

Indexed keywords

B7 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; DIAMOND; DPV 576 C; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; NANOMATERIAL; PLATINUM; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; AQUEOUS SOLUTION; ARTICLE; CANCER THERAPY; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MONOCYTE; PRIORITY JOURNAL; UPREGULATION;

CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COATED MATERIALS, BIOCOMPATIBLE; CYTOKINES; DENDRITIC CELLS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; METAL NANOPARTICLES; MONOCYTES; NANODIAMONDS; PLATINUM;

EID: 78650231489     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. El-Sayed IH, Huang X and El-Sayed MA: Selective laser photothermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett 239: 129-133, 2006.
2. Lu J, Liong M, Sherman S, Xia T, Kovochich M, Nel AE, Zink JI and Tamanoi F: Mesoporous silica nanoparticles for cancer therapy: energy-dependent cellular uptake and delivery of paclitaxel to cancer cells. Nanobiotechnol 3: 89-95, 2007.
3. Greiner NR, Phillips DS, Johnson JD and Volk F: Diamonds in detonation soot. Nature 333: 440-442, 1988.
4. Dai L (ed.): Carbon Nanotechnology: Recent Developments in Chemistry, Physics, Materials Science and Device Applications; Elsevier: Amsterdam, 2006.
5. Grichko V, Grishko V and Shenderova O: Nanodiamond bullets and their biological targets. Nanobiotechnol 2: 37-42, 2007.
6. Huang LC and Chang HC: Adsorption and immobilization of cytochrome c on nanodiamonds. Langmuir 20: 5879-5884, 2004.
7. Hikosaka M, Kim J, Kajita M, Kanayama A and Miyamoto Y: Platinum nanoparticles have an activity similar to mitochondrial NADH: ubiquinone oxidoreductase. Colloid Surfaces B: Biointerfaces 2: 195-200, 2008.
8. Barone M, Sciortino MT, Zaccaria D, Mazzaglia A and Sortino, S: Nitric oxide photocaging platinum nanoparticles with anticancer potential. J Mater Chem 18: 5531-5536, 2008.
9. Dhara S, Gub FX, Langer R, Farokhzad OC and Lippard SJ: Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proc Natl Acad Sci USA 105: 17356-17361, 2008.
10. Ghoneum M, Ghoneum A, Tolentino L and Gimzewski J: Modulation of aged murine T lymphocytes in vivo by DPV576-C, a nanodiamond- and nanoplatinum-coated material. In Vivo 24: 2141-2146, 2010.
11. Bancherau J and Steinman RM: Dendritic cells and the control of immunity. Nature 392: 245-252, 1998.
12. Agrawal S, Agrawal A, Doughty B, Gerwitz A, Blenis J, Van Dyke T and Pulendran B: Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal regulated kinase-mitogen-activated protein kinase and c-Fos. J Immunol 171: 4984-4989, 2003.
13. Agrawal A, Kaushal P, Agrawal S, Gollapudi S and Gupta S: Thimerosal induces TH2 responses via influencing cytokine secretion by human dendritic cells. J Leukoc Biol 81: 474-482, 2007.
14. Roediger B, Ng LG, Smith AL, Fazekas DSGB and Weninger W: Visualizing dendritic cell migration within the skin. Histochem Cell Biol 130: 1131-1146, 2008
15. Henri S, Guilliams M, Poulin LF, Tamoutounour S, Ardouin L, Dalod M and Malissen B: Disentangling the complexity of the skin dendritic cell network. Immunol Cell Biol 88: 366-375, 2010.
16. Schreiber HA, Prechl J, Jiang H, Zozulya A, Fabry Z, Denes F and Sandor M: Using carbon magnetic nanoparticles to target, track, and manipulate dendritic cells. J Immunol Methods 2010, in press.
17. Mesa C, De Leon J, Rigley K and Fernandez LE: Very small size proteoliposomes derived from Neisseria meningitidis: An effective adjuvant for Th1 induction and dendritic cell activation. Vaccine 22: 3045-3052, 2004.
18. Elamanchili P, Diwan M, Cao M and Samuel J: Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells. Vaccine 22: 2406-2412, 2004.
19. Uto T, Wang X, Sato K, Haraguchi M, Akagi T, Akashi M and Baba M: Targeting of antigen to dendritic cells with poly(gamma-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity. J Immunol 178: 2979-2986, 2007.
20. Mottram P L, Leong D, Crimeen-Irwin B, Gloster S, Xiang SD, Meanger J, Ghildyal R, Vardaxis N and Plebanski M: Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: Formulation of a model vaccine for respiratory syncytial virus. Mol Pharmaceutics 4: 73-84, 2007.
21. Reece JC, Vardaxis NJ, Marshall JA, Crowe SM and Cameron PU: Uptake of HIV and latex particles by fresh and cultured dendritic cells and monocytes. Immunol Cell Biol 79: 255-263, 2001.
22. Nel AE, Mδdler L, Velegol D, Xia T, Hoek EM, Somasundaran P, Klaessig F, Castranova V and Thompson M: Understanding biophysicochemical interactions at the nano-bio interface. Nature Materials 8: 543-557, 2009.
23. Verma A and Stellacci F: Effect of surface properties on nanoparticle-cell interactions. Small 6: 12-21, 2010.
24. Schrand AM, Huang H, Carlson C, Schlager JJ, Omacr Sawa E, Hussain SM and Dai L: Are nanodiamonds cytotoxic? J Phys Chem B 111: 2-7, 2007.
25. Seya T, Shime H, Ebihara T, Oshiumi H and Matsumoto M: Pattern recognition receptors of innate immunity and their application to tumor immunotherapy. Cancer Sci. 10: 313-320, 2010.
26. Kaden SA, Kurig S, Vasters K, Hofmann K, Zaenker KS, Schmitz J and Winkels G: Enhanced dendritic cell-induced immune responses mediated by the novel C-type lectin receptor mDCAR1. J Immunol 183: 5069-5078, 2009.